These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9419755)

  • 21. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of estramustine and its constituents on human malignant glioma cells.
    von Schoultz E; Lundgren E; Henriksson R
    Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
    Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
    Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological studies of estramustine phosphate as a novel radiation sensitizer.
    Kim JH; Khil MS; Kim SH; Ryu S; Gabel M
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):555-7. PubMed ID: 8005815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that estramustine binds MAP-1A to inhibit type IV collagenase secretion.
    Stearns ME; Wang M; Sousa O
    J Cell Sci; 1991 Jan; 98 ( Pt 1)():55-63. PubMed ID: 1647395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
    Günthert AR; Gründker C; Hollmann K; Emons G
    Biochem Biophys Res Commun; 2002 May; 294(1):11-5. PubMed ID: 12054733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer.
    Pienta KJ; Smith DC
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-72-S15-77. PubMed ID: 9346227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
    Tang X; Lu M; Li C; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects.
    Edgren M; Westlin JE; Letocha H; Nordgren H; Kälkner KM; Nilsson S
    Acta Oncol; 1996; 35(4):483-8. PubMed ID: 8695166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
    von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
    Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
    Stearns ME; Tew KD
    Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estramustine in malignant glioma.
    Bergenheim AT; Henriksson R; Piepmeier JM; Yoshida D
    J Neurooncol; 1996 Oct; 30(1):81-9. PubMed ID: 8865006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
    Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
    Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxol suppresses dynamics of individual microtubules in living human tumor cells.
    Yvon AM; Wadsworth P; Jordan MA
    Mol Biol Cell; 1999 Apr; 10(4):947-59. PubMed ID: 10198049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of taxol on two human cancer cell lines.
    Banerjee S; Fallis AG; Brown DL
    Oncol Res; 1997; 9(5):237-48. PubMed ID: 9306431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of lipophilins as determinants of tumor cell response to estramustine.
    Tucker JM; Lipatova Z; Beljanski V; Townsend DM; Tew KD
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1158-62. PubMed ID: 16120813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3.
    Roigas J; Wallen ES; Loening SA; Moseley PL
    Urol Res; 2002 May; 30(2):130-5. PubMed ID: 12086019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.